Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Nucleic acid encoding an E1A gene product sensitizes HER-2/neu overexpressing cancer cells to chemotherapy

Nucleic acid encoding an E1A gene product sensitizes HER-2/neu overexpressing cancer cells to chemotherapy

US Patent 7005424 · Granted Feb 28, 2006

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for selecting antibodies that specifically bind glycosylated immune chec2024
Antibodies specific to glycosylated PD-1 and methods of use thereof2024
Antibodies specific to glycosylated PD-L1 and methods of use thereof2024
Methods of cancer treatment and therapy using a combination of antibodies that b2023
Dual function antibodies specific to glycosylated PD-L1 and methods of use there2023
Detection of arginine methylation of EGFR for prediction of resistance to therap2022
Antibodies specific to glycosylated PD-1 and methods of use thereof2020
Antibodies specific to glycosylated PD-L1 and methods of use thereof2020
Detection of arginine methylation of EGFR for prediction of resistance to therap2020
Prediction of response to PARP inhibitors and combinational therapy targeting C-2019
Personalized medicine for the prediction of therapy targeting the hedgehog pathw2017
Methods for detecting molecule-molecule interactions with a single detection cha2013